Prediction of left ventricular reverse remodeling after therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and β blockers in patients with idiopathic dilated cardiomyopathy

[1] Dec GW(1994)Idiopathic dilated cardiomyopathy N Engl J Med 331 1564-75

[2] Fuster V(1999)Prevalence, predictors, and prognosis of reversal of maladaptive remodeling with intensive medical therapy in idiopathic dilated cardiomyopathy Am J Cardiol 84 671-6

[3] Kawai K(2002)Relation between left ventricular remodeling and clinical outcomes in heart failure patients with left ventricular systolic dysfunction J Card Fail 8 S465-71

[4] Takaoka H(2005)Reliability of ventricular remodeling as a surrogate for use in conjunction with clinical outcomes in heart failure Am J Cardiol 96 867-71

[5] Hata K(2011)Effect of left ventricular reverse remodeling on long-term prognosis after therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and β blockers in patients with idiopathic dilated cardiomyopathy Am J Cardiol 107 1065-70

[6] Yokota Y(2010)Quantitative evaluation of drug or device effects on ventricular remodeling as predictors of therapeutic effects on mortality in patients with heart failure and reduced ejection fraction: a meta-analytic approach J Am Coll Cardiol 56 392-406

[7] Yokoyama M(2011)Left ventricular remodeling in heart failure: current concepts in clinical significance and assessment JACC Cardiovasc Imaging 4 98-108

[8] Udelson JE(2011)Prevalence and prognostic significance of left ventricular reverse remodeling in dilated cardiomyopathy receiving tailored medical treatment J Am Coll Cardiol 57 1468-76

[9] Konstam MA(2011)Ventricular remodeling fundamental to the progression (and regression) of heart failure J Am Coll Cardiol 57 1477-9

[10] Konstam MA(2013)Left ventricular reverse remodeling in long-term (>12 years) survivors with idiopathic dilated cardiomyopathy Am J Cardiol 111 106-10

[1] Dec GW(1994)Idiopathic dilated cardiomyopathy N Engl J Med 331 1564-75

[2] Fuster V(1999)Prevalence, predictors, and prognosis of reversal of maladaptive remodeling with intensive medical therapy in idiopathic dilated cardiomyopathy Am J Cardiol 84 671-6

[3] Kawai K(2002)Relation between left ventricular remodeling and clinical outcomes in heart failure patients with left ventricular systolic dysfunction J Card Fail 8 S465-71

[4] Takaoka H(2005)Reliability of ventricular remodeling as a surrogate for use in conjunction with clinical outcomes in heart failure Am J Cardiol 96 867-71

[5] Hata K(2011)Effect of left ventricular reverse remodeling on long-term prognosis after therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and β blockers in patients with idiopathic dilated cardiomyopathy Am J Cardiol 107 1065-70

[6] Yokota Y(2010)Quantitative evaluation of drug or device effects on ventricular remodeling as predictors of therapeutic effects on mortality in patients with heart failure and reduced ejection fraction: a meta-analytic approach J Am Coll Cardiol 56 392-406

[7] Yokoyama M(2011)Left ventricular remodeling in heart failure: current concepts in clinical significance and assessment JACC Cardiovasc Imaging 4 98-108

[8] Udelson JE(2011)Prevalence and prognostic significance of left ventricular reverse remodeling in dilated cardiomyopathy receiving tailored medical treatment J Am Coll Cardiol 57 1468-76

[9] Konstam MA(2011)Ventricular remodeling fundamental to the progression (and regression) of heart failure J Am Coll Cardiol 57 1477-9

[10] Konstam MA(2013)Left ventricular reverse remodeling in long-term (>12 years) survivors with idiopathic dilated cardiomyopathy Am J Cardiol 111 106-10